# A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body.

> **NCT06392230** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Oral [14C] PF-06821497
- **DRUG:** Oral PF-06821497
- **DRUG:** IV [14C] PF-06821497

## Key facts

- **NCT ID:** NCT06392230
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-30
- **Primary completion:** 2024-11-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392230, "A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06392230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*